Alexza resubmits AZ-004 NDA for treatment of agitation in schizophrenia patients Alexza Pharmaceuticals, Inc. announced today that it provides resubmitted its AZ-004 New Drug Software to the U.S http://edpillsotc.com . Food and Medication Administration in response to a Complete ResponseContinue reading… Announced today that it provides resubmitted its AZ-004 New Drug Software to the U.
Howson, John A. King, Jiri Michal and Andrew L. Turner, effective upon the close of the deal. The addition of Michael and Peter brings significant knowledge from Allergan to your Board, and I welcome their expertise and insights as weContinue reading… PRESS RELEASE DUBLIN.